It is appealing to suppose that H3B achieves selectivity by having a greater affinity for mutant SF3B1, but it is unclear how this could occur considering that the site of the K700E mutation (and other common cancer-associated SF3B1 mutations) is located far from the SM binding site. The gene discussed is SF3B1; the disease is cancer.